We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance.
- Authors
Schmidt, S.; Rainer, J.; Ploner, C.; Presul, E.; Riml, S.; Kofler, R.
- Abstract
The ability of glucocorticoids (GC) to efficiently kill lymphoid cells has led to their inclusion in essentially all chemotherapy protocols for lymphoid malignancies. This review summarizes recent findings related to the molecular basis of GC-induced apoptosis and GC resistance, and discusses their potential clinical implications. Accumulating evidence suggests that GC may induce cell death via different pathways resulting in apoptotic or necrotic morphologies, depending on the availability/responsiveness of the apoptotic machinery. The former might result from regulation of typical apoptosis genes such as members of the Bcl-2 family, the latter from detrimental GC effects on essential cellular functions possibly perpetuated by GC receptor (GR) autoinduction. Although other possibilities exist, GC resistance might frequently result from defective GR expression, perhaps the most efficient means to target multiple antileukemic GC effects. Numerous novel drug combinations are currently being tested to prevent resistance and improve GC efficacy in the therapy of lymphoid malignancies.Cell Death and Differentiation (2004) 11, S45-S55. doi:10.1038/sj.cdd.4401456
- Subjects
CELL death; APOPTOSIS; GLUCOCORTICOID receptors; ADRENOCORTICAL hormones; CANCER patients; DRUG therapy
- Publication
Cell Death & Differentiation, 2004, Vol 11, pS45
- ISSN
1350-9047
- Publication type
Article
- DOI
10.1038/sj.cdd.4401456